CD4 c.28T>A ;(p.L10M)

Variant ID: 12-6909332-T-A

NM_000616.4(CD4):c.28T>A;(p.L10M)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Third-Line Antiretroviral Therapy: What Do We Do When the Appropriate Formulations Are Not Available?

Children (Basel, Switzerland)
Frigati, Lisa Jane LJ; Rabie, Helena H
Publication Date: 2022-03-30

Variant appearance in text: CD4: L10M
PubMed Link: 35455517
Variant Present in the following documents:
  • children-09-00473.pdf
View BVdb publication page



Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance.

Aids Research And Therapy
Wolf, Eva E; Boesecke, Christoph C; Balogh, Annamaria A; Bidner, Helen H; Cordes, Christiane C; Heiken, Hans H; Krznaric, Ivanka I; Kümmerle, Tim T; Stellbrink, Hans-Jürgen HJ; Schneider, Jochen J; Spinner, Christoph D CD; ,
Publication Date: 2021-09-08

Variant appearance in text: CD4: L10M
PubMed Link: 34496848
Variant Present in the following documents:
  • Main text
  • 12981_2021_Article_384.pdf
View BVdb publication page



Polymorphisms and drug resistance analysis of HIV-1 isolates from patients on first line antiretroviral therapy (ART) in South-eastern Nigeria.

Plos One
Udeze, Augustine O AO; Olaleye, David O DO; Odaibo, Georgina N GN
Publication Date: 2020

Variant appearance in text: CD4: L10M
PubMed Link: 32267869
Variant Present in the following documents:
  • Main text
  • pone.0231031.pdf
View BVdb publication page



Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen.

Antimicrobial Agents And Chemotherapy
Doualla-Bell, Florence F; Avalos, Ava A; Gaolathe, Tendani T; Mine, Madisa M; Gaseitsiwe, Simani S; Ndwapi, Ndwapi N; Novitsky, Vladimir A VA; Brenner, Bluma B; Oliveira, Maureen M; Moisi, Daniella D; Moffat, Howard H; Thior, Ibou I; Essex, Max M; Wainberg, Mark A MA
Publication Date: 2006-06

Variant appearance in text: CD4: L10M
PubMed Link: 16723586
Variant Present in the following documents:
  • Main text
View BVdb publication page



R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.

Antimicrobial Agents And Chemotherapy
Masquelier, Bernard B; Droz, Cecile C; Dary, Martin M; Perronne, Christian C; Ferré, Virginie V; Spire, Bruno B; Descamps, Diane D; Raffi, François F; Brun-Vézinet, Françoise F; Chêne, Geneviève G; ,
Publication Date: 2003-11

Variant appearance in text: CD4: L10M
PubMed Link: 14576131
Variant Present in the following documents:
  • Main text
View BVdb publication page